Exactly. Also surprised this thread has not going nuts over this...
According to the ASCO presentation the Imprinter PD1-vaxx study (NCT04432207) in P1a had
1 CR
1 PR
7 SD
So thats 9out of12, 75 percent patients had good responses in Stage 3b or 4 nsclc after failing previous SoC treatments. IMHO, this sounds excellent.
Good luck all.
Media Thread, page-5618
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.1¢ | 4.8¢ | $1.062M | 21.65M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 5138497 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 6291273 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |